Fabrication of FeNi@PDA Nanozyme-Driven Dual-Mode Platform for Visual and On-Site Monitoring of Ampicillin

Read full text
Authors: Weipeng Teng, Guizhu Wu, Hongwu Wu, Zhaoying Liu, Haining Chen, Zhen Zhang, M Li
Cited by: 1
References: 38

Abstract

The widespread accumulation of ampicillin (AMP) poses significant ecological and health risks, demanding rapid and portable monitoring tools. Herein, a Fe-Ni bimetallic-doped polydopamine (FeNi@PDA) nanozyme with exceptional peroxidase-like activity was synthesized for the visual and on-site monitoring of AMP. Optimized through bimetallic electronic coupling, FeNi@PDA exhibited enhanced catalytic efficiency (KM = 0.051 mmol/L for H2O2 and 0.049 mmol/L for 3,3′,5,5′-tetramethylbenzidine) and generated 1O2 and ·O2− via H2O2 activation. Leveraging the competitive consumption of reactive oxygen species (ROS) by electron-rich AMP, a colorimetry detection mode was developed where AMP concentration inversely correlated with oxidized 3,3′,5,5′-tetramethylbenzidine (oxTMB) formation. This strategy achieved a good linear relationship of between 0.05 to 100 μg/mL, with a limit of detection (LOD) of 10.38 ng/mL. Furthermore, a smartphone-integrated paper-based detection mode was fabricated by immobilizing FeNi@PDA on filter paper. The color gradient of test papers, analyzed via smartphone imaging, enabled on-site AMP quantification with a LOD of 340 ng/mL. This work not only developed a novel Fe-Ni bimetallic nanozyme with enhanced peroxidase-like activity and established a competitive ROS-consumption sensing mechanism but also pioneered a dual-mode detection platform for low-cost, user-friendly ampicillin monitoring in environmental samples.

Fields of Study & Subjects

Advanced Nanomaterials in Catalysis Advanced biosensing and bioanalysis techniques Nanoplatforms for cancer theranostics

Publication details

Journal / source
Catalysts
Publisher
MDPI AG
Volume
16
Issue
6
Pages
489–489
Publication date
22 May 2026
Language
EN